发明名称 Novel derivatives of 2-hydroxytetrahydrofuran and their use as medicaments
摘要 The invention relates to derivatives of 2-hydroxytetrahydrofuran corresponding to general formula (I) in which A represents the radical, in which R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>4</SUP>, R<SUP>5 </SUP>and R<SUP>6 </SUP>represent (in particular), independently, H, a halogen atom, OH, alkyl or alkoxy, R<SUP>3 </SUP>represents H, alkyl or -COR<SUP>10</SUP>, R<SUP>10 </SUP>representing H, alkyl or alkoxy, and W represents a bond, -CH<SUB>2</SUB>-CH<SUB>2</SUB>-, -CH-CH-, -O-, -S- or -NR<SUP>11</SUP>- in which R<SUP>11 </SUP>represents H or alkyl; X represents -CO-, -Y-CO-, -O-Y-CO- or -NR<SUP>12</SUP>-Y-CO-, Y represents an alkylene or haloalkylene alkyl, R<SUP>12 </SUP>represents H, alkyl or -COR<SUP>13</SUP>, R<SUP>13 </SUP>represents H, alkyl, haloalkyl or alkoxy, AA represents, each time that it occurs, a natural or non-natural amino acid; n represents 2 or 3; and finally R represents H, alkyl or -CO-R<SUP>19</SUP>, R<SUP>19 </SUP>representing alkyl. These compounds have a calpain inhibiting activity and/or an activity which traps the reactive oxygen species and can be used for preparing a medicament intended to treat the inflammatory and immunological diseases, cardio-vascular and cerebro-vascular diseases, disorders of the central or peripheral nervous system, cachexia, osteoporosis, muscular dystrophy, proliferative diseases, cataract, rejection reactions following organ transplants and autoimmune and viral diseases.
申请公布号 US2005222045(A1) 申请公布日期 2005.10.06
申请号 US20050115480 申请日期 2005.04.27
申请人 AUVIN SERGE;CHABRIER DE LASSAUNIERE PIERRE 发明人 AUVIN SERGE;CHABRIER DE LASSAUNIERE PIERRE-ETIENNE
分类号 A61K38/00;C07K5/06;C07K5/065;C07K5/068;C07K5/078;C07K5/097;C07K5/117;(IPC1-7):A61K38/05;A61K38/04;A61K31/541;A61K31/55;A61K31/538 主分类号 A61K38/00
代理机构 代理人
主权项
地址